Dr. Carlos Fernandez Hernando's lab focuses on understanding how lipid metabolism affects immune responses in cardiovascular diseases, particularly atherosclerosis. They study novel enzymes and lipid molecules that help regulate inflammation and cholesterol levels in macrophages, which are immune cells involved in artery health. By investigating these pathways, the lab aims to uncover potential treatments that can improve cardiovascular health by targeting the underlying causes of inflammation and lipid imbalances.

Dr. Kimberly Dougherty's lab focuses on understanding how spinal cord injuries (SCI) affect locomotion and what biological mechanisms can be targeted to improve recovery. Through her research, the lab investigates how changes in spinal cord circuits can both aid and hinder motor function recovery after injury. The team studies the spatiotemporal dynamics of spinal networks to identify potential therapeutic strategies that could restore walking in individuals with SCI.

Dr. Andrew Vaughan's research lab focuses on understanding how the lungs repair themselves after injury from respiratory viruses like influenza and SARS-CoV-2. They investigate the regeneration of both the epithelial and endothelial layers of lung tissue, aiming to uncover the molecular pathways that support recovery and prevent severe complications such as acute respiratory distress syndrome (ARDS). The lab's work is crucial for developing therapies to improve lung function and reduce mortality rates associated with viral pneumonia.

Dr. Jonathan Kipnis's lab at Washington University focuses on understanding how the immune system influences brain function and contributes to age-related cognitive decline and diseases like Alzheimer's. The research explores the role of meningeal lymphatics and immune cells in maintaining cognitive health, especially in older adults. The lab aims to develop innovative treatments that may enhance brain health by modulating immune responses.

Dr. Robert B. West's lab at Stanford University focuses on breast cancer research, particularly the progression of ductal carcinoma in situ (DCIS) to invasive breast cancer (IBC). The lab studies how certain immune cells, particularly macrophages, behave in the tumor microenvironment to identify new biomarkers that could predict cancer progression. Their research aims to improve our understanding of cancer biology and to better predict patient outcomes based on specific tumor characteristics.

Dr. Adrienne Antonson's lab focuses on understanding how maternal influenza infections affect fetal brain development. They investigate the immune signaling pathways that cross from mother to fetus and how these affect the baby's brain. By using advanced techniques, the lab aims to find ways to mitigate the negative impacts of such infections, potentially leading to strategies that could protect both mothers and their unborn children from neurodevelopmental disorders.

Dr. Matija Snuderl's lab at NYU School of Medicine focuses on understanding medulloblastoma, the most common malignant brain tumor in children. The team investigates how certain biological processes can be harnessed to induce maturation in these tumors, making them less aggressive and more treatable. Through advanced techniques in genetics and drug delivery, the lab aims to develop new therapies that are less toxic than current treatments.

Dr. Roberto Bonasio's lab at the University of Pennsylvania studies how memories can be encoded in organisms beyond the nervous system, using planarians, a type of flatworm capable of regenerating their brains. The lab investigates the molecular mechanisms behind memory retention and transmission through both neural and non-neural pathways. Their work aims to enhance our understanding of memory formation and inheritance, with potential insights applicable to more complex brains, including human brains.

Dr. Jiang Chang's lab focuses on understanding heart failure, particularly the metabolism of heart cells and how energy supply affects heart function. They are investigating a system called metabolic resuscitation, which could potentially be manipulated to improve treatments for heart failure. By using experimental approaches and animal models, the lab aims to identify new therapeutic strategies and biomarkers for heart failure management.

Dr. Wei Gu's lab at Columbia University focuses on understanding how the p53 tumor suppressor protein regulates metabolism to inhibit tumor growth. By investigating the metabolic pathways influenced by p53, the lab aims to find new therapeutic targets that can effectively suppress cancer while minimizing damage to healthy tissues. This research is particularly important as it explores unconventional mechanisms of tumor suppression, which may open up new avenues for cancer treatment.

Dr. Marcia Haigis's lab at Harvard Medical School focuses on understanding how cellular metabolism drives the initiation and progression of colorectal cancer (CRC). The research particularly investigates the role of a protein family called sirtuins, specifically SIRT4, in regulating metabolic changes associated with cancer and chemotherapy resistance. By exploring how SIRT4 influences cell growth and survival through metabolic pathways, the lab aims to pave the way for new and effective cancer therapies.

Dr. Srinivas Malladi's lab focuses on understanding how certain types of breast cancer cells survive and metastasize to the brain. The research aims to uncover mechanisms that allow cancer cells to evade the immune system and resist therapy. By exploring the roles of specific proteins and immune interactions, the lab seeks to develop strategies that may enhance treatment responses and combat metastasis in breast cancer patients.

Dr. Dan Littman's lab at NYU School of Medicine focuses on how the gut microbiome influences the effectiveness of immunotherapy in lung cancer. By studying specific bacterial species and their products, the lab aims to uncover mechanisms that enhance immune responses against tumors, potentially leading to better treatment outcomes for patients. This research could help identify which patients may benefit most from immunotherapy and reduce harmful side effects.

Dr. Irina Kaverina's lab focuses on understanding how the structural components of cells, specifically microtubules and their associated motor proteins, influence the function of insulin-producing beta cells. Through their research, the lab aims to uncover mechanisms that regulate insulin secretion, which is critical in managing blood sugar levels and preventing conditions like diabetes. By using advanced microscopy and modeling techniques, the lab investigates how these cellular components can be manipulated to improve beta cell function and glucose homeostasis.

Dr. David Charles Dallas's lab at Oregon State University focuses on understanding how different handling practices of human milk affect the release and activity of beneficial peptides in the intestines of preterm infants. Through their research, they aim to discover the best methods to handle and fortify human milk to support healthy growth and development in neonates. This lab's work is crucial for improving nutrition strategies for preterm infants in neonatal intensive care units.

Dr. Jorge Ivan Alvarez's lab at the University of Pennsylvania focuses on understanding how mitochondria affect the blood-brain barrier (BBB) and their connection to neuropsychiatric disorders. They investigate how deficiencies in mitochondrial function can compromise BBB integrity, which may lead to conditions like schizophrenia and other neurodevelopmental disorders. The lab combines insights from neuroimmunology and developmental biology to explore new therapeutic approaches for these conditions.

Dr. Gerald W. Dorn's lab focuses on understanding how mitochondria function and adapt in heart cells, especially during conditions like cardiomyopathy and heart failure. They explore the role of a protein called Mitofusin 2 in regulating mitochondrial dynamics and metabolism, aiming to find new therapeutic approaches to improve heart health. The research combines basic science and translational applications to address critical challenges in heart disease treatment.

Dr. Richard T Lee's lab at Harvard University focuses on understanding the role of mitochondria and specific proteins in heart function and heart diseases, particularly cardiomyopathy. The lab uses advanced gene editing techniques to investigate mitochondrial DNA mutations and their effects on heart muscle cells, as well as the signaling roles of growth differentiation factors in heart health. This research aims to uncover crucial mechanisms that could lead to new therapies for mitochondrial diseases and heart-related conditions.

Dr. Liza A Pon's lab at Columbia University focuses on understanding how proteins are properly synthesized, folded, and degraded within cells, particularly in the mitochondria and endoplasmic reticulum. They investigate the processes that maintain protein quality control, which is crucial for preventing diseases related to protein misfolding, such as neurodegenerative disorders and muscular dystrophy. Through their research, they aim to uncover new mechanisms that might help in treating these serious health conditions.

Dr. Jeffrey M. Spraggins' lab at Vanderbilt University focuses on understanding the molecular basis of kidney diseases and Alzheimer's disease through advanced imaging techniques. By utilizing cutting-edge multimodal imaging and spatially resolved molecular technologies, the lab aims to identify key pathways in these diseases, helping to uncover potential biomarkers and therapeutic targets. The research combines expertise in nephrology, analytical chemistry, and cell biology, making it a hub for innovative biomedical discovery.